Literature DB >> 15243731

Stepping over obstacles: anticipatory modifications in children with and without Down syndrome.

Naznin Virji-Babul1, Michelle Brown.   

Abstract

The purpose of this study was to explore the mechanism of anticipatory control of gait in relation to the perception of an obstacle. Typically developing (TD) children (4-7 years of age) and children with Down syndrome (5-6 years of age) walked and stepped over obstacles of two different heights-a "subtle" obstacle that was placed at a very low distance from the floor (1% of total body height) and an "obvious" obstacle that was placed at a much higher distance from the floor (15% of total body height). Spatial and temporal measures of the gait cycle were analyzed. TD children showed increased variability in pre-obstacle step lengths only in response to the higher obstacle. Children with DS showed a decrease in variability in response to the higher obstacle and marked qualitative changes in their gait cycle. Both groups of children were able to scale toe clearance with obstacle height. These results show that TD young children can make task-specific anticipatory adjustments by modulating step length and toe clearance. Children with DS show appropriate scaling of toe clearance and are beginning to show the emergence of anticipatory responses under specific environmental conditions.

Entities:  

Mesh:

Year:  2004        PMID: 15243731     DOI: 10.1007/s00221-004-1971-5

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  5 in total

1.  Anticipatory locomotor control for obstacle avoidance in mid-childhood aged children.

Authors:  B J McFadyen; F Malouin; F Dumas
Journal:  Gait Posture       Date:  2001-02       Impact factor: 2.840

2.  A model of the neuro-musculo-skeletal system for anticipatory adjustment of human locomotion during obstacle avoidance.

Authors:  G Taga
Journal:  Biol Cybern       Date:  1998-01       Impact factor: 2.086

3.  The motor deficit in Down's syndrome children: a problem of timing?

Authors:  S E Henderson; J Morris; U Frith
Journal:  J Child Psychol Psychiatry       Date:  1981-07       Impact factor: 8.982

4.  Where and when do we look as we approach and step over an obstacle in the travel path?

Authors:  A E Patla; J N Vickers
Journal:  Neuroreport       Date:  1997-12-01       Impact factor: 1.837

5.  The build-up of anticipatory behaviour. An analysis of the development of gait initiation in children.

Authors:  A Ledebt; B Bril; Y Brenière
Journal:  Exp Brain Res       Date:  1998-05       Impact factor: 1.972

  5 in total
  5 in total

1.  Strategy adoption and locomotor adjustment in obstacle clearance of newly walking toddlers with Down syndrome after different treadmill interventions.

Authors:  Jianhua Wu; Dale A Ulrich; Julia Looper; Chad W Tiernan; Rosa M Angulo-Barroso
Journal:  Exp Brain Res       Date:  2007-12-07       Impact factor: 1.972

2.  Spatiotemporal and kinematic aspects of obstacle avoidance in subjects with Down syndrome.

Authors:  Sara Laura Vimercati; Manuela Galli; Chiara Rigoldi; Andrea Ancillao; Giorgio Albertini
Journal:  Funct Neurol       Date:  2012 Oct-Dec

3.  Evaluation of Motor Skills in Children with Rubinstein-Taybi Syndrome.

Authors:  Jean René Cazalets; Emma Bestaven; Emilie Doat; Marie Pierre Baudier; Cécile Gallot; Anouck Amestoy; Manuel Bouvard; Etienne Guillaud; Isabelle Guillain; Emelyne Grech; Julien Van-Gils; Patricia Fergelot; Sonia Fraisse; Emmanuelle Taupiac; Benoit Arveiler; Didier Lacombe
Journal:  J Autism Dev Disord       Date:  2017-11

4.  Response abilities of children with Down Syndrome and other intellectual developmental disorders.

Authors:  Pratiksha Tilak Rao; Vasudeva Guddattu; John Michael Solomon
Journal:  Exp Brain Res       Date:  2017-02-24       Impact factor: 1.972

5.  Feedback reliance during an arm-tapping task with obstacle avoidance in adults with Down syndrome.

Authors:  Sara Laura Vimercati; Manuela Galli; Chiara Rigoldi; Andrea Ancillao; Giorgio Albertini
Journal:  Exp Brain Res       Date:  2013-03-26       Impact factor: 1.972

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.